Frankfurt Stock Exchange

EQS-News: Multitude SE: Decisions of the Annual General Meeting of Shareholders and the Board of Directors of Multitude SE

Retrieved on: 
Friday, May 3, 2024
Annual general meeting, Annual, Remuneration, WKN, Chapter Ten, Committee, EUR, Malta Business Registry, Frankfurt Stock Exchange, Fintech, PwC, European, Register, Management

The Annual General Meeting approved the presented Remuneration Report for Governing Bodies and supported the presented Remuneration Policy for Governing Bodies.

Key Points: 
  • The Annual General Meeting approved the presented Remuneration Report for Governing Bodies and supported the presented Remuneration Policy for Governing Bodies.
  • The Annual General Meeting confirmed the number of members of the Board of Directors as six.
  • The Chairman and the Vice Chairman of the Board of Directors will be elected by the Board of Directors from amongst its members.
  • The Board of Directors decided to re-elect Ari Tiukkanen as the Chair of the Board of Directors and Jorma Jokela as the Vice Chair of the Board of Directors.

EQS-News: Bastei Lübbe AG continues growth with community-driven business models through new publishing brand pola

Retrieved on: 
Friday, May 3, 2024
Woman, Book, Bastei, LYX, Business development, Life, Frankfurt Stock Exchange, Publishing, Growth

Bastei Lübbe AG is consistently focusing on growth in the community sector.

Key Points: 
  • Bastei Lübbe AG is consistently focusing on growth in the community sector.
  • "We are thus consistently pursuing our strategic path of growth through innovation leadership in this area.
  • Now, with pola, we are adding another high-potential publishing brand for young women," explains Soheil Dastyari, CEO of Bastei Lübbe AG.
  • Parallel to the development of the new brand, another course was set: Ruža Kelava has also been in charge of the Lübbe publishing brand together with publishing director Marco Schneiders since 1 April 2024.

EQS-News: MPH Health Care AG: Preliminary IFRS result 2023 Equity increases by almost 30 million euros to 251.0 million euros, which corresponds to 58.62 euros per share. EBIT increases to 30.2 million euros.

Retrieved on: 
Friday, May 3, 2024
Investment, NAV, AG, Frankfurt Stock Exchange, Tax, MPH, M1 Group, Beauty

MPH Health Care AG: Preliminary IFRS result 2023 Equity increases by almost 30 million euros to 251.0 million euros, which corresponds to 58.62 euros per share.

Key Points: 
  • MPH Health Care AG: Preliminary IFRS result 2023 Equity increases by almost 30 million euros to 251.0 million euros, which corresponds to 58.62 euros per share.
  • Equity (net asset value) increases by almost 30 million euros to 251.0 million euros, which corresponds to 58.62 euros per share.
  • Berlin, 25 April 2024 - MPH Health Care AG (ISIN: DE000A289V03) announces the preliminary IFRS consolidated result for the 2023 financial year.
  • As of 31 December 2023, equity increased by EUR 29.6 million to EUR 251.0 million (previous year: EUR 221.4 million).

EQS-News: Delisting tender offer to KATEK shareholders published

Retrieved on: 
Friday, May 3, 2024
Regulated market, Frankfurt Stock Exchange, Internet, Security (finance)

Linz, 15.04.2024 – The documents to the shareholders of KATEK SE have been published.

Key Points: 
  • Linz, 15.04.2024 – The documents to the shareholders of KATEK SE have been published.
  • The offer price is EUR 15 per KATEK share in cash.
  • Kontron Acquisition GmbH (“Bidder”), an indirect, wholly owned Kontron subsidiary, has today published the offer document for the mandatory offer to the shareholders of KATEK SE.
  • Alternatively, it is possible to exchange 4 KATEK shares for 3 Kontron shares (share consideration).

EQS-News: Hawesko Group defies challenging market conditions: Sales and profitability remain at a high level in 2023

Retrieved on: 
Friday, May 3, 2024
Wine, HAW, AI, Partnership, Environment, Frankfurt Stock Exchange, Perception, Annual report, Growth, Retail

Hawesko Group defies challenging market conditions: Sales and profitability remain at a high level in 2023

Key Points: 
  • Hawesko Group defies challenging market conditions: Sales and profitability remain at a high level in 2023
    The issuer is solely responsible for the content of this announcement.
  • Hawesko Group defies challenging market conditions: Sales and profitability remain at a high level in 2023
    Hawesko Group holds its own in a challenging environment with falling consumer spending and a declining wine market: sales are almost on a par with the previous year.
  • Thorsten Hermelink, CEO of the Hawesko Group, commented as follows: "In the 2023 financial year, we succeeded in continuing our development of recent years at a high level, despite a very tricky economic environment.
  • The persistently challenging market conditions already led to systematic cost reductions in all segments of the Hawesko Group at the start of 2023.

EQS-News: Fourth acquisition in 2024: Mutares has successfully completed the acquisition of Greenview Group Holdings Ltd from Cordovan Capital Management Ltd and its current management

Retrieved on: 
Friday, May 3, 2024
Goods, SDAX, Heat, EUR, Growth, Frankfurt Stock Exchange, Supervisory board, Acquisition, HQ, Regulated market, Private sector, Holding company, MUX

Munich, April 22, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has successfully completed the acquisition of Greenview Group Holdings Ltd from Cordovan Capital Partners II LP and Michael Burke, the group’s current CEO.

Key Points: 
  • Munich, April 22, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has successfully completed the acquisition of Greenview Group Holdings Ltd from Cordovan Capital Partners II LP and Michael Burke, the group’s current CEO.
  • EUR 36 million in 2023 and is forecast to deliver EUR 45 million in the current financial year to March 2025.
  • As the portfolio grows, so do consulting revenues, which together with portfolio dividends and exit proceeds accrue to the Mutares Holding.
  • The Management Board and Supervisory Board together hold more than one-third of all Mutares shares with voting rights.

EQS-News: Karlsberg Brauerei: New 2024/2029 bond successfully placed

Retrieved on: 
Friday, May 3, 2024
Oslo Stock Exchange, Gesellschaft mit beschränkter Haftung, Investment, WKN, EUR, Nordic, Frankfurt Stock Exchange, Deutsch, Karlsberg (brewery), Security (finance)

Homburg, 19 April 2024 - Karlsberg Brauerei GmbH has successfully placed its fourth corporate bond (ISIN: NO0013168005, WKN: A3825C).

Key Points: 
  • Homburg, 19 April 2024 - Karlsberg Brauerei GmbH has successfully placed its fourth corporate bond (ISIN: NO0013168005, WKN: A3825C).
  • The new 2024/2029 bond met with great interest from both private and institutional investors in Germany and abroad and was significantly oversubscribed.
  • The net issue proceeds of the 2024/2029 bond after exchange will be used to refinance the outstanding 2020/2025 bond that has not yet been submitted for exchange.
  • To this end, Karlsberg Brauerei GmbH will give notice in the next few days to cancel the 2020/2025 bond that has not already been exchanged as part of this transaction.

EQS-News: HomeToGo Announces Results of Public Share Tender Offer

Retrieved on: 
Friday, May 3, 2024
Sale, AMERICA, NOT, Treasury, Software as a service, Frankfurt Stock Exchange, HTG, THIS, Share repurchase

At the Final Purchase Price of €2.00 per share, a total of 2,729,251 Class A shares were validly tendered to the Company for buyback.

Key Points: 
  • At the Final Purchase Price of €2.00 per share, a total of 2,729,251 Class A shares were validly tendered to the Company for buyback.
  • The total number of 1,249,991 Class A shares to be repurchased under the public share tender offer corresponds to around 1.0% of all HomeToGo shares.
  • Each custodian bank is instructed to credit the purchase price to the account specified in the relevant HomeToGo shareholder’s declaration of acceptance.
  • Taking into account the approximately €1.1 million of share repurchases via the stock exchange under this ongoing share buyback program so far, the total remaining volume for further repurchases amounts to approximately €6.4 million.

EQS-News: Shelly Group AD: Inclusion in trading on XETRA opens up broader investor base

Retrieved on: 
Friday, May 3, 2024
Baader Bank AG, XETRA, Internet of things, Bulgarian Stock Exchange, Frankfurt Stock Exchange, Regulated market, Ticker, Growth

As of Monday, 29 April 2024, Shelly shares listed in the Prime Standard of the Frankfurt Stock Exchange will be traded on XETRA.

Key Points: 
  • As of Monday, 29 April 2024, Shelly shares listed in the Prime Standard of the Frankfurt Stock Exchange will be traded on XETRA.
  • Consequently, Shelly Group will be the first Bulgarian company to be traded on XETRA.
  • By uplisting from specialist trading on the Frankfurt Stock Exchange to the fully electronic trading platform XETRA, the company expects more liquid trading in Shelly shares and the development of a broader investor base.
  • Dimitar Dimitrov, Co-CEO of Shelly Group, commented: “We are extremely proud to be the first company from Bulgaria to be included in trading on XETRA.

Medigene AG reports Financial Results and Business Update for Q1 2024

Retrieved on: 
Friday, April 26, 2024
Prospectus, Synovial sarcoma, Tissue, Federal Gazette, TCE, Partnership, EUR, Stomach, European, Exercise, Frankfurt Stock Exchange, BioNTech, Regeneron Pharmaceuticals, Patient, Supervisory board, Toxicity, IIT, AACR, Senior, TCR, Annual general meeting, Annual report, Cancer, Ovarian cancer, Pharmaceutical industry

Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today reported financial results for the first quarter of 2024.

Key Points: 
  • Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and development of T cell immunotherapies for solid tumors, today reported financial results for the first quarter of 2024.
  • The full Quarterly Statement Q1 2024 can be downloaded here: https://medigene.com/investors-media/reports-presentations/ .
  • The financial performance in Q1 2024 was in line with the Executive Management Board’s expectations.
  • The subscription period for the new shares commenced on April 24, 2024 and ends on May 7, 2024 at 24:00 hours (CEST).